Skip to main content

Table 2 Candidate mitochondrial genes and complexes for each cancer type

From: Cancerouspdomains: comprehensive analysis of cancer type-specific recurrent somatic mutations in proteins and domains

Cancer Type

Genes (Percentage)

Complexes (Percentage)

ACC

MT-TL1 (32.6)

-

BRCA

MT-RNR1 (3.6), MT-RNR2 (5.6), MT-TT (0.8)

rRNA (8.4)

CHOL

MT-RNR2 (33.3)

rRNA (33.3)

ESCA

MT-CYB (13.7)

COMPLEX III (13.7)

HNSC

MT-ND5 (1)

-

KICH

MT-ND1 (13.6)

-

LIHC

MT-ND5 (12.9)

COMPLEX I (18.3)

LUAD

-

COMPLEX III (1.1)

PRAD

MT-RNR2 (1.9)

-

SARC

MT-RNR2 (12.6), MT-CO2 (7.1)

rRNA (14.2), COMPLEX IV (15.7)

TGCT

-

COMPLEX III (6.3)

THYM

MT-RNR2 (27.6)

rRNA (27.6)

UCEC

MT-RNR1 (11.7), MT-RNR2 (11.7), MT-TV (12)

rRNA (0.41.7)

Pan Cancer

MT-RNR2, MT-CYB

rRNA, COMPLEX III